Allstate Corporation’s Chemours CC Stock Holding History

Allstate Corporation’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-64,833	Closed	-$2.41M	–	486
2019 Q1	$2.41M	Hold	64,833	–	–	0.06%	221
2018 Q4	$1.83M	Buy	+64,833	New	+$2.05M	0.06%	227

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allstate Corporation's CC Position: Q2 2019 in Review

Allstate Corporation sold out of Chemours (CC) in Q2 2019, closing a stake of 64,833 shares — an estimated $2.41M sold.

Allstate Corporation first reported a position in CC in Q4 2018 and held it in 2 quarters. The position peaked at $2.41M in Q1 2019. 488 funds tracked by Wall St. Rank hold CC as of Q2 2019.

Allstate Corporation reported no remaining Chemours position as of Q2 2019 after selling out during the quarter.
Allstate Corporation sold 64,833 Chemours shares in Q2 2019, an estimated $2.41M.
Allstate Corporation first reported a position in Chemours in Q4 2018 and held it in 2 quarters.
Allstate Corporation's Chemours position peaked at $2.41M in Q1 2019.
488 funds tracked by Wall St. Rank held Chemours as of Q2 2019.

Based on Allstate Corporation's 13F filing for Q2 2019, filed 14 Aug 2019.